OCT-1 as a determinant of response to antileukemic treatment.

Item

http://www.wikidata.org/entity/Q54610682

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

OCT-1 as a determinant of response to antileukemic treatment.

@en

OCT-1 as a determinant of response to antileukemic treatment.

@nl

type

Item

label

OCT-1 as a determinant of response to antileukemic treatment.

@en

OCT-1 as a determinant of response to antileukemic treatment.

@nl

prefLabel

OCT-1 as a determinant of response to antileukemic treatment.

@en

OCT-1 as a determinant of response to antileukemic treatment.

@nl

P1476

OCT-1 as a determinant of response to antileukemic treatment.

@en

P2093

J R Engler

http://www.w3.org/2001/XMLSchema#string

T P Hughes

http://www.w3.org/2001/XMLSchema#string

P2860

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1

Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences

Drug excretion mediated by a new prototype of polyspecific transporter

Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimizati

Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistance.

Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.

Active transport of imatinib into and out of cells: implications for drug resistance.

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

Regulation of organic cation transport.

Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.

P304

608-611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CLPT.2011.12

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Deborah L. White

P577

2011-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49967435

http://www.w3.org/2001/XMLSchema#string

P698

21346750

http://www.w3.org/2001/XMLSchema#string